PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance
暂无分享,去创建一个
A. Vincent-Salomon | S. Vacher | A. Nicolas | I. Bièche | V. Bernard | S. Pancholi | M. Leal | P. Cottu | T. Larcher | W. Chemlali | D. Meseure | G. Dutertre | M. Bohec | S. Baulande | C. Reyes | E. Marangoni | D. Gentien | A. Rapinat | D. Decaudin | R. El Botty | F. Némati | A. Dahmani | Ricardo Ribas | M. Le Romancer | Nikiana Simigdala | J. Nikitorowicz-Buniak | L. Morisset | E. Montaudon | L. Sourd | K. Driouch | F. Coussy | Zakia Tariq | L. Huguet | P. Painsec | É. Montaudon | Camilla Rega | S. Chateau-Joubert | J. Masliah-Planchon | L. Martin